| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/09/2006 | EP1687427A2 Methods for modulating neuronal responses |
| 08/09/2006 | EP1687333A2 Method for down-regulation of vegf |
| 08/09/2006 | EP1290032B1 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1165099B1 Angiotensin ii and analogs thereof for limiting scar and adhesion formation |
| 08/09/2006 | EP1073891B1 Method of predicting receptor modulating activity |
| 08/09/2006 | EP1051619B1 Method for identifying t-cell stimulating protein fragments |
| 08/09/2006 | EP1037650B1 Compositions for the treatment of staphylococcus aureus infections |
| 08/09/2006 | EP0951472B1 Peptide compositions with growth factor-like activity |
| 08/09/2006 | CN1814618A Japanese schistosome metalloproteuse minic peptide and its screening method and use |
| 08/09/2006 | CN1268762C Corn peptide and its preparation and use |
| 08/09/2006 | CN1268636C Dolastatin 15 derivatives |
| 08/08/2006 | US7087732 Nucleotides and analogs having photoremovable protecting groups |
| 08/08/2006 | US7087717 Comprises nucleotide sequences coding nuclear hormone receptor co-activator for diagnosis and treatment of liver disorders |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087372 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 08/08/2006 | US7087231 In situ diagnosis of malaria |
| 08/08/2006 | CA2092680C Epstein-barr virus sequences and protein thereof |
| 08/03/2006 | WO2006080920A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/03/2006 | WO2006080142A1 Hla-binding peptides, dna fragments encoding the same and recombinant vectors |
| 08/03/2006 | WO2006063470B1 Metabolites of cyclosporin analogs |
| 08/03/2006 | WO2006057997A3 Plasmin-inhibitory therapies |
| 08/03/2006 | WO2006008266A3 Factor xi-binding proteins |
| 08/03/2006 | WO2005117940A9 Cell death modulation via antagonists of fasl and fas activation |
| 08/03/2006 | WO2005085288A3 Natural igm antibodies and inhibitors thereof |
| 08/03/2006 | WO2004007746A3 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN |
| 08/03/2006 | US20060173163 Preparation of T-1249 peptides using two fragments that are synthesized using a solid phase approach; excellent purity and yield |
| 08/03/2006 | US20060173160 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172948 Gamma-carboxyglutamate containing conopeptides |
| 08/03/2006 | US20060172947 Physiologically active peptides and drugs containing the same |
| 08/03/2006 | US20060172943 Restoring vascular function |
| 08/03/2006 | US20060172940 Glycosylated mucocidin antimicrobial peptide, ophthalmic formulation, inhibiting microbial growth |
| 08/03/2006 | US20060172931 Heparin-binding peptides and uses thereof |
| 08/03/2006 | US20060172926 Aplidine for multiple myeloma treatment |
| 08/03/2006 | US20060172363 Peptide complexes containing phospholipase d |
| 08/03/2006 | US20060172327 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | CA2593801A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/02/2006 | EP1685153A1 Targeting compositions and preparation thereof |
| 08/02/2006 | EP1684788A2 Peptide increasing fusiogenic capacity of a gamete |
| 08/02/2006 | EP1511761B1 Process for production of cyclic peptides |
| 08/02/2006 | EP1450843B1 Use of thymulin-like peptides for making pain-relieving medicines |
| 08/02/2006 | EP0979243B1 Activation of peptides |
| 08/02/2006 | EP0737208B1 Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 08/02/2006 | CN1812997A Pharmaceutical composition |
| 08/02/2006 | CN1810829A Prepn process of octreotide acetate |
| 08/02/2006 | CN1267452C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267449C Methods and compositions for peptide synthesis |
| 08/02/2006 | CN1267148C Use of GnRH antagonists in prevention of diabetes by administration |
| 08/01/2006 | US7084247 Identification of self and non-self antigens implicated in autoimmune diseases |
| 08/01/2006 | US7084245 Peptides that bind to the erythropoietin receptor |
| 08/01/2006 | US7084244 Formed by means of bridging groups attached via the alpha nitrogens of amino acid derivatives to provide novel non-peptidic linkages; backbone cyclized bradykinin antagonists having biological activity |
| 08/01/2006 | US7084241 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 08/01/2006 | US7084240 Crystallization of IGF-1 |
| 08/01/2006 | US7084239 stimulates cancer antigen specific cytotoxic T lymphocytes; useful in cancer diagnostics and immunotherapeutics including a cancer vaccine. |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084110 Anticarcinogenic agents for treating cancer; pentapeptides, hexapeptides, heptapeptides, oligopeptides |
| 08/01/2006 | US7084109 FVIIa antagonists |
| 08/01/2006 | US7084108 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 08/01/2006 | US7083983 Inhibitors of the interaction between P53 and MDM2 |
| 08/01/2006 | US7083797 32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
| 08/01/2006 | CA2165435C Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 07/27/2006 | WO2006078268A2 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 07/27/2006 | WO2006078161A1 Binding compounds, immunogenic compounds and peptidomimetics |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006077941A1 Cancer vaccine |
| 07/27/2006 | WO2006077035A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 07/27/2006 | WO2006055806A9 Diagnostic, prognostic, and therapeutic factor smac/diablo in human cancer |
| 07/27/2006 | WO2006042661A3 Oligopeptides and their use in cosmetics |
| 07/27/2006 | WO2005100381A3 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 07/27/2006 | WO2005076009A3 Method for identifying and quantifying of tumour-associated peptides |
| 07/27/2006 | WO2005002516A9 Leukocyte internalized peptide-drug conjugates |
| 07/27/2006 | US20060168682 Plant peptide with antimicrobial activity |
| 07/27/2006 | US20060167229 Biologically active peptide conjugates |
| 07/27/2006 | US20060167224 Novel functional peptide nucleic acid and process for producing the same |
| 07/27/2006 | US20060167223 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/27/2006 | US20060166892 Treatment of cell proliferative disorders with chlorotoxin |
| 07/27/2006 | US20060166891 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 07/27/2006 | US20060166890 Non-t cell binding peptides and their uses |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166888 for arachidonic acid release in target cells; intracellular calcium release; phospholipases |
| 07/27/2006 | US20060166883 Novel antimicrobial peptides based on tripeptide repeats |
| 07/27/2006 | US20060166869 Novel use of lipopeptide preparations |
| 07/27/2006 | US20060166868 Vegf peptides and their use |
| 07/27/2006 | US20060166863 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/27/2006 | US20060166858 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/27/2006 | US20060165715 Gp41 inhibitor |
| 07/27/2006 | US20060165714 Peptides for vaccination against human CMV |
| 07/27/2006 | DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications |
| 07/27/2006 | CA2598607A1 Methods and compositions for cell-cycle regulation |
| 07/27/2006 | CA2595902A1 Binding compounds, immunogenic compounds and peptidomimetics of the beta-3 hairpin loop of cystine-knot growth factors |
| 07/27/2006 | CA2595063A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | CA2594423A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 07/27/2006 | CA2592500A1 Methods of increasing cerebral blood flow |
| 07/27/2006 | CA2563823A1 Beta-peptides |
| 07/26/2006 | EP1684073A2 Target sequences for synthetic molecules and methods of using same |
| 07/26/2006 | EP1683803A1 Water soluble prodrugs of hindered alcohols or phenols |